60 Degrees Pharmaceuticals(SXTP.US)

Last Updated 19:00:00 ET
longbridge loading

60 Degrees Pharmaceuticals 1Q 2026: Revenue $162.09K, EPS ($1.28) — 10-Q Summary

TradingView·
US
SXTPW
-0.50%
US
SXTP
+3.60%
US
GDRX
+2.88%
TradingView·
US
SXTPW
-0.50%
US
SXTP
+3.60%
US
GDRX
+2.88%

60 Degrees Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 162.09 K

Earnings Watch·
US
SXTP
+3.60%
Earnings Watch·
US
SXTP
+3.60%

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results | SXTP Stock News

StockTitan·
US
SXTP
+3.60%
US
BIB
-3.74%
US
SBIO
-3.43%
StockTitan·
US
SXTP
+3.60%
US
BIB
-3.74%
US
SBIO
-3.43%

SXTP Q1'26 Earnings: EPS estimate is (0.76) USD

TradingView·
US
SXTP
+3.60%
US
XBI
-2.31%
US
PBE
-0.58%
TradingView·
US
SXTP
+3.60%
US
XBI
-2.31%
US
PBE
-0.58%

60 Degrees Pharmaceuticals shares are trading higher. The company reported its Q4 financial results.

benzinga_article·
US
BIB
-3.74%
US
SXTPW
-0.50%
US
LABU
-6.92%
benzinga_article·
US
BIB
-3.74%
US
SXTPW
-0.50%
US
LABU
-6.92%

60 Degrees Pharmaceuticals Announces 2025 Annual Results | SXTP Stock News

StockTitan·
US
SXTPW
-0.50%
US
XBI
-2.31%
US
VHT
+0.30%
StockTitan·
US
SXTPW
-0.50%
US
XBI
-2.31%
US
VHT
+0.30%

60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract | SXTP Stock News

StockTitan·
US
BIB
-3.74%
US
SXTPW
-0.50%
US
IXJ
+0.51%
StockTitan·
US
BIB
-3.74%
US
SXTPW
-0.50%
US
IXJ
+0.51%
© 2026 Longbridge｜Disclaimer